Planned intervention: On Wednesday April 3rd 05:30 UTC Zenodo will be unavailable for up to 2-10 minutes to perform a storage cluster upgrade.
Published July 8, 2022 | Version v1
Presentation Open

Implementation of water-soluble crosslinked cyclodextrin-based polymers for light-activated combination therapy

  • 1. CNR
  • 2. Cyclolab

Description

Abstract submitted for the Supramol2022 conference in Salerno in June 2022. Manet I was invited to give a keynote lecture.

Files

extract keynote.pdf

Files (10.3 MB)

Name Size Download all
md5:88720234b70621d46290b4ad56bebb59
10.2 MB Preview Download
md5:7ecd636a8fde4f22059fd4a2b03104a3
62.0 kB Preview Download

Additional details

Funding

HypoCyclo – Multifunctional Polymeric Cyclodextrin Nanocarriers As Novel Triple-Negative Breast Cancer Treatment: A Versatile Photo-Chemotherapy Bypassing Hypoxic Conditions 894942
European Commission
CYCLON HIT – NANOCARRIERS FOR THE DELIVERY OF ANTIMICROBIAL AGENTS TO FIGHT RESISTANCE MECHANISMS 608407
European Commission
CYCLON – Novel multifunctional cyclodextrin-based nanocarriers for drug encapsulation and delivery as a strategy to overcome current therapeutic drawbacks. 237962
European Commission
POLAR STAR – Polymeric cyclodextrin-based nanoparticles for combination therapy of castrate-resistant prostate cancer 843014
European Commission